Read news as it happens
Create a Rediffmail account
Subscribe via RSS
After US, India to probe Ranbaxy's documents
After US, India to probe Ranbaxy’s documents SUSHMI DEY New Delhi, 22 May Health ministry tells DCGI to examine past dossiers, drug applications In what could be the beginning of fresh......
Sensex soars 237 points ahead of Brexit poll outcome
After witnessing lacklustre trades in the past two sessions, markets shot up in today’s trade after Britons commenced voting on a referendum on whether Britain should remain a part of......
How safe are cheap medicines made in India?
An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active......
Drug makers seek out-of-court settlement in clinical trial cases
In order to keep pace with the government’s healthcare agenda, the pharmaceutical sector wants research work to go on, at any cost. In a letter to health minister Harsh Vardhan, the Indian......
Why is Novartis likely to lose Tiamulin drug licence?
Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2017 Rediff.com